2018
DOI: 10.1177/1724600818766500
|View full text |Cite
|
Sign up to set email alerts
|

Identification of circulating microRNAs as diagnostic biomarkers for ovarian cancer: A pooled analysis of individual studies

Abstract: Circulating miRNAs, especially the combination of multiple circulating miRNAs, are promising biomarkers for the diagnosis of ovarian cancer. However, further large-scale prospective studies are necessary to validate the applicability of the miRNAs in the early detection of ovarian cancer.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 51 publications
(79 reference statements)
0
3
0
Order By: Relevance
“…Some studies have evaluated the efficacy of CA-125 in OC and found an optimal sensitivity and specificity of 0.74 and 0.83, respectively Goff et al, 2017). In a meta-analysis conducted by Zhou et al (2018), the pooled sensitivity and specificity a panel of circulating miRNAs was 0.76 and 0.81 (95% CI 0.74 -0.87), with a high diagnostic accuracy corresponding to an area under the curve (AUC) of up to 0.85. Thus, the accuracy of circulating miRNAs for the diagnosis of OC may be greater compared with traditional biomarkers.…”
Section: Clinically Standard Biomarkers Vs Circulating Mirnasmentioning
confidence: 99%
“…Some studies have evaluated the efficacy of CA-125 in OC and found an optimal sensitivity and specificity of 0.74 and 0.83, respectively Goff et al, 2017). In a meta-analysis conducted by Zhou et al (2018), the pooled sensitivity and specificity a panel of circulating miRNAs was 0.76 and 0.81 (95% CI 0.74 -0.87), with a high diagnostic accuracy corresponding to an area under the curve (AUC) of up to 0.85. Thus, the accuracy of circulating miRNAs for the diagnosis of OC may be greater compared with traditional biomarkers.…”
Section: Clinically Standard Biomarkers Vs Circulating Mirnasmentioning
confidence: 99%
“…[121][122][123] Forster resonance energy transfer (FRET) is another optical method of detetion which is based on radiation-less transfer of electronic excitation from a "donor" molecule to an "acceptor" molecule due to dipole-dipole interaction between the two molecules. 124 One of the latest optical platforms for quantifying absolute miRNAs was demonstrated by Qiu et al 125,126 They established a ratiometric and single-step detection assay using isothermal amplification of miR-21, miR-132 and miR-146a based on time-gated FRET (TG-FRET) between Tb donors and dye acceptors which resulted in miRNA assays with single-nucleotide variant specificity and detection limits down to 4.2 ± 0.5 attomoles. 125,126 In actual case, they modified RCA-FRET miRNA assay demonstrated by Wu et al using steady-state detection of two fluorescent dyes as FRET pair.…”
Section: Optical Sensorsmentioning
confidence: 99%
“…124 One of the latest optical platforms for quantifying absolute miRNAs was demonstrated by Qiu et al 125,126 They established a ratiometric and single-step detection assay using isothermal amplification of miR-21, miR-132 and miR-146a based on time-gated FRET (TG-FRET) between Tb donors and dye acceptors which resulted in miRNA assays with single-nucleotide variant specificity and detection limits down to 4.2 ± 0.5 attomoles. 125,126 In actual case, they modified RCA-FRET miRNA assay demonstrated by Wu et al using steady-state detection of two fluorescent dyes as FRET pair. 127 Although their proof of concept study could achieve an LOD as low as 103 aM and steadfast detection above background of 6 fM, the main limitation of this platform is that it was tested on only a small number of samples.…”
Section: Optical Sensorsmentioning
confidence: 99%